Literature DB >> 2663759

Does the kind of immunosuppressive therapy influence plasma renin activity, aldosterone and vasopressin in patients with a kidney transplant?

T Nieszporek1, W Grzeszczak, F Kokot, E Zukovska-Szczechowska, A Wiecek, S Kusmierski, A Szkodny.   

Abstract

In 24 patients with a functioning kidney transplant and in 33 healthy subjects plasma renin activity (PRA), plasma aldosterone and vasopressin (AVP) levels were assessed under basal conditions and after dietary sodium restriction. Twelve patients were treated with azathioprine and another 12 with cyclosporine A. From the results obtained it seems that immunosuppressive drugs used in transplanted patients ar involved in the pathogenesis of endocrine abnormalities and that the kind of immunosuppressive therapy is of minor importance in their development of maintenance. Transplanted kidneys show a preserved reaction pattern of renin secretion to sodium deprivation and upright position.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663759     DOI: 10.1007/bf02550813

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  3 in total

1.  Effects of naloxone administration on endocrine abnormalities in chronic renal failure.

Authors:  W Grzeszczak; F Kokot; J Duława
Journal:  Am J Nephrol       Date:  1987       Impact factor: 3.754

2.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

3.  Hyperkalaemia in cyclosporin-treated renal allograft recipients.

Authors:  D Adu; J Turney; J Michael; P McMaster
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

  3 in total
  1 in total

1.  The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.

Authors:  Naim Issa; Fernando Ortiz; Scott A Reule; Aleksandra Kukla; Bertram L Kasiske; Michael Mauer; Scott Jackson; Arthur J Matas; Hassan N Ibrahim; Behzad Najafian
Journal:  Kidney Int       Date:  2013-08-21       Impact factor: 10.612

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.